gla 27 has been researched along with HIV in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bozzacco, L; Brane, L; Cheong, C; Dandamudi, D; Longhi, MP; Mehandru, S; Pantel, A; Ruane, D; Shrestha, E; Steinman, RM; Teixeira, A | 1 |
1 other study(ies) available for gla 27 and HIV
Article | Year |
---|---|
A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Dendritic Cells; HIV; HIV Core Protein p24; Lipid A; Lymphoid Tissue; Mice; Mice, Inbred C57BL; Mice, Knockout; Specific Pathogen-Free Organisms; Toll-Like Receptor 4; Vaccines, Subunit | 2012 |